Peptide Receptor Radionuclide Therapy with (177)Lu-DOTATATE in a Case of Concurrent Neuroendocrine Tumors and Meningioma: Achieving Two Things in a Single Action

We present a partial response of peptide receptor radionuclide therapy (PRRT) with (177)Lu-DOTATATE in a case of concurrent neuroendocrine tumors (NETs) and meningioma. In addition to the valuable role of PRRT in inoperable NETs, it has been demonstrated that this treatment can be a promising therap...

Descripción completa

Detalles Bibliográficos
Autores principales: Assadi, Majid, Rekabpour, Seyed Javad, Amini, Abdullatif, Dadgar, Habibollah, Nemati, Reza, Gholamrezanezhad, Ali, Nabipour, Iraj, Jafari, Esmail, Ahmadzadehfar, Hojjat
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Galenos Publishing 2021
Materias:
Interesting Image
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8185482/
https://www.ncbi.nlm.nih.gov/pubmed/34082512
http://dx.doi.org/10.4274/mirt.galenos.2020.69783

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8185482/
https://www.ncbi.nlm.nih.gov/pubmed/34082512
http://dx.doi.org/10.4274/mirt.galenos.2020.69783

Ejemplares similares